11 results on '"Thorsteinsson, B."'
Search Results
2. Effects of continuous glucose monitor-recorded nocturnal hypoglycaemia on quality of life and mood during daily life in type 1 diabetes.
- Author
-
Henriksen MM, Andersen HU, Thorsteinsson B, and Pedersen-Bjergaard U
- Subjects
- Adult, Aged, Awareness, Biomarkers blood, Diabetes Mellitus, Type 1 blood, Diabetes Mellitus, Type 1 psychology, Female, Health Knowledge, Attitudes, Practice, Humans, Hypoglycemia blood, Hypoglycemia psychology, Male, Middle Aged, Predictive Value of Tests, Prospective Studies, Time Factors, Affect, Blood Glucose metabolism, Blood Glucose Self-Monitoring instrumentation, Diabetes Mellitus, Type 1 diagnosis, Hypoglycemia diagnosis, Monitoring, Ambulatory instrumentation, Quality of Life
- Abstract
Aims/hypothesis: The aim of this work was to assess the effect of spontaneous nocturnal hypoglycaemia on quality of life and mood during subsequent days in type 1 diabetes., Methods: A total of 153 people with type 1 diabetes participated in 6 days of blinded continuous glucose monitoring while documenting hypoglycaemic symptoms, quality of life and mood, daily. Hypoglycaemia was defined by interstitial glucose ≤3.9 mmol/l (IG
3.9 ) and ≤ 3.0 mmol/l (IG3.0 ) for ≥15 min and was classified as asymptomatic if no hypoglycaemic symptoms were reported., Results: Self-estimated quality of life assessed by the EQ-5D VAS (but not by the WHO Well-Being Index) was higher the day after asymptomatic (but not after symptomatic) hypoglycaemic nights, as compared with non-hypoglycaemic nights (IG3.9 , p = 0.021; IG3.0 , p = 0.048). The effect increased with lower glucose nadir and longer duration of nocturnal hypoglycaemia (IG3.9 , p = 0.03). The finding was confined to participants with impaired hypoglycaemia awareness. There was no effect of nocturnal hypoglycaemia on mood or self-estimated effectiveness at work the following day., Conclusions/interpretation: Individuals with type 1 diabetes and impaired hypoglycaemia awareness reported higher quality of life on days preceded by nights with asymptomatic (but not symptomatic) hypoglycaemia. The effect was amplified by lower glucose nadir and longer duration of the episodes and may help explain resistance to implementation of interventions to reduce hypoglycaemia in many people with impaired hypoglycaemia awareness.- Published
- 2021
- Full Text
- View/download PDF
3. Effect of Metformin vs. Placebo in Combination with Insulin Analogues on Bone Markers P1NP and CTX in Patients with Type 2 Diabetes Mellitus.
- Author
-
Nordklint AK, Almdal TP, Vestergaard P, Lundby-Christensen L, Jørgensen NR, Boesgaard TW, Breum L, Gade-Rasmussen B, Sneppen SB, Gluud C, Hemmingsen B, Krarup T, Madsbad S, Mathiesen ER, Perrild H, Tarnow L, Thorsteinsson B, Vestergaard H, Lund SS, and Eiken P
- Subjects
- Biomarkers, C-Reactive Protein, Collagen Type I, Glycated Hemoglobin, Humans, Peptide Fragments, Peptides, Procollagen, Bone Remodeling drug effects, Diabetes Mellitus, Type 2 drug therapy, Insulin analogs & derivatives, Insulin therapeutic use, Metformin therapeutic use
- Abstract
Preclinical studies have shown a potential osteoanabolic effect of metformin but human studies of how metformin affects bone turnover are few. A post hoc sub-study analysis of an 18-month multicenter, placebo-controlled, double-blinded trial in type 2 diabetes mellitus (T2DM), randomizing participants to metformin versus placebo both in combination with different insulin analogue regimens (Metformin + Insulin vs. Placebo + Insulin). Patients were not treatment naive at baseline, 83% had received metformin, 69% had received insulin, 57.5% had received the combination of metformin and insulin before entering the study. Bone formation and resorption were assessed by measuring, N-terminal propeptide of type I procollagen (P1NP) and C-terminal telopeptide of type I collagen (CTX) at baseline and end of study. The influence of gender, age, smoking, body mass index (BMI), T2DM duration, glycosylated hemoglobin A1c (HbA1c), c-reactive protein (CRP) and insulin dosage was also included in the analyses. The levels of bone formation marker P1NP and bone resorption marker CTX increased significantly in both groups during the trial. P1NP increased less in the Metformin + Insulin compared to the placebo + insulin group (p = 0.001) (between group difference change), while the increases in CTX levels (p = 0.11) were not different. CRP was inversely associated (p = 0.012) and insulin dosage (p = 0.011) was positively related with change in P1NP levels. BMI (p = 0.002) and HbA1C (p = 0.037) were inversely associated with change in CTX levels. During 18 months of treatment with metformin or placebo, both in combination with insulin, bone turnover increased in both groups. But the pattern was different as the bone formation marker (P1NP) increased less during Metformin + Insulin treatment, while change in bone resorption (CTX) was not significantly different between the two groups.
- Published
- 2020
- Full Text
- View/download PDF
4. Infrared thermographic assessment of changes in skin temperature during hypoglycaemia in patients with type 1 diabetes.
- Author
-
Sejling AS, Lange KH, Frandsen CS, Diemar SS, Tarnow L, Faber J, Holst JJ, Hartmann B, Hilsted L, Kjaer TW, Juhl CB, Thorsteinsson B, and Pedersen-Bjergaard U
- Subjects
- Adult, Aged, Blood Glucose analysis, Diabetes Mellitus, Type 1 blood, Female, Humans, Hypoglycemia blood, Insulin blood, Male, Middle Aged, Awareness physiology, Diabetes Mellitus, Type 1 physiopathology, Hypoglycemia physiopathology, Skin Temperature physiology
- Abstract
Aims/hypothesis: Hypoglycaemia is associated with reduced skin temperature (Ts). We studied whether infrared thermography can detect Ts changes during hypoglycaemia in patients with type 1 diabetes and how the Ts response differs between patients with normal hypoglycaemia awareness and hypoglycaemia unawareness., Methods: Twenty-four patients with type 1 diabetes (ten aware, 14 unaware) were studied during normoglycaemia (5.0-6.0 mmol/l), hypoglycaemia (2.0-2.5 mmol/l) and during recovery from hypoglycaemia (5.0-6.0 mmol/l) using hyperinsulinaemic glucose clamping. During each 1 h phase, Ts was measured twice by infrared thermography imaging in pre-defined areas (nose, glabella and the five left fingertips), symptoms of hypoglycaemia were scored and blood was sampled., Results: Ts decreased during hypoglycaemia on the nose and glabella. The highest decrements were recorded on the nose (aware: -2.6 °C, unaware: -1.1 °C). In aware patients, the differences in temperature were statistically significant on both nose and glabella, whereas there was only a trend in the unaware group. There was a significant difference in hypoglycaemia-induced temperature changes between the groups. Patients in the aware group had higher hypoglycaemia symptom scores and higher adrenaline (epinephrine) levels during hypoglycaemia., Conclusions/interpretation: The hypoglycaemia-associated decrement in Ts can be assessed by infrared thermography and is larger in patients with normal hypoglycaemia awareness compared with unaware patients.
- Published
- 2015
- Full Text
- View/download PDF
5. A high concentration of prorenin in early pregnancy is associated with development of pre-eclampsia in women with type 1 diabetes.
- Author
-
Ringholm L, Pedersen-Bjergaard U, Thorsteinsson B, Boomsma F, Damm P, and Mathiesen ER
- Subjects
- Adult, Diabetes Mellitus, Type 1 epidemiology, Female, Humans, Pre-Eclampsia epidemiology, Pregnancy, Prospective Studies, Young Adult, Diabetes Mellitus, Type 1 blood, Diabetes Mellitus, Type 1 complications, Pre-Eclampsia blood, Pre-Eclampsia etiology, Renin blood
- Abstract
Aims/hypothesis: The aim of this study was to investigate whether components of the renin-angiotensin system and semicarbazide-sensitive amine oxidase (SSAO) are associated with the development of pre-eclampsia in women with type 1 diabetes., Methods: This was an observational study of 107 consecutive pregnant women with type 1 diabetes (median duration 16 years [range 1-36 years], HbA(1c) 6.6% [range 4.9-10.5%]) in early pregnancy. At 8, 14, 21, 27 and 33 weeks and once within 5 days postpartum, blood was sampled for measurements of prorenin, renin, angiotensinogen, ACE and SSAO. HbA(1c), blood pressure and urinary albumin excretion were recorded. Pre-eclampsia was defined as blood pressure >140/90 mmHg and proteinuria ≥300 mg/24 h after 20 weeks., Results: Pre-eclampsia developed in nine women (8%) with longer diabetes duration (median 20 [range 10-32] vs 16 [range 1-36] years, p = 0.04), higher SSAO concentrations (592 [range 372-914] vs 522 [range 264-872] mU/l, p = 0.04) and a tendency towards higher prorenin levels (136 [range 50-296] vs 101 [range 21-316] ng angiotensin I ml(-1) h(-1), p = 0.06) at 8 weeks compared with women without pre-eclampsia. Levels of renin, angiotensinogen and ACE did not differ in the two groups. Throughout pregnancy, prorenin and SSAO levels were 30% (p = 0.004) and 16% (p = 0.04) higher, respectively, in women developing pre-eclampsia. Using multivariate logistic regression analysis, prorenin concentration at 8 weeks was associated with pre-eclampsia (OR 4.4 [95% CI 1.5-13.0], p = 0.007), i.e. an increase of prorenin of 100 ng angiotensin I ml(-1) h(-1) implies a 4.4 times higher risk of subsequent pre-eclampsia., Conclusions/interpretation: In type 1 diabetic women with pre-eclampsia, a higher concentration of prorenin in early pregnancy and higher levels of prorenin and SSAO throughout pregnancy were seen.
- Published
- 2011
- Full Text
- View/download PDF
6. The Somogyi phenomenon revisited using continuous glucose monitoring in daily life.
- Author
-
Høi-Hansen T, Pedersen-Bjergaard U, and Thorsteinsson B
- Subjects
- Adult, Cohort Studies, Diabetes Mellitus, Type 1 etiology, Diabetes Mellitus, Type 1 therapy, Female, Humans, Hypoglycemia etiology, Male, Middle Aged, Blood Glucose analysis, Diabetes Mellitus, Type 1 physiopathology, Hyperglycemia etiology
- Published
- 2005
- Full Text
- View/download PDF
7. Association between plasma activities of semicarbazide-sensitive amine oxidase and angiotensin-converting enzyme in patients with type 1 diabetes mellitus.
- Author
-
Boomsma F, Pedersen-Bjergaard U, Agerholm-Larsen B, Hut H, Dhamrait SS, Thorsteinsson B, and van den Meiracker AH
- Subjects
- Angiotensin-Converting Enzyme Inhibitors therapeutic use, Body Mass Index, Diabetes Mellitus, Type 1 enzymology, Diabetic Angiopathies blood, Diabetic Foot blood, Diabetic Foot surgery, Diabetic Nephropathies blood, Diabetic Neuropathies blood, Diabetic Retinopathy blood, Glycated Hemoglobin analysis, Humans, Peptidyl-Dipeptidase A genetics, Amine Oxidase (Copper-Containing) blood, Diabetes Mellitus, Type 1 blood, Peptidyl-Dipeptidase A blood
- Abstract
Aims/hypothesis: Plasma semicarbazide-sensitive amine oxidase (SSAO) is elevated in patients with type 1 and type 2 diabetes and has been implicated in the pathophysiology of diabetic late complications. The regulation of SSAO production remains unknown. We studied correlations between plasma SSAO activity and parameters associated with diabetic late complications., Methods: Plasma SSAO was measured in a well-characterised group of 287 patients with type 1 diabetes. Standard statistical methods were used to investigate correlations with clinical parameters and components of the renin-angiotensin system., Results: Overall, plasma SSAO was elevated, at 693+/-196 mU/l (mean+/-SD; normal controls 352+/-102 mU/l). Plasma SSAO was higher in the group with late complications or hypertension, and in patients treated with ACE-inhibitors. In univariate analysis a significant positive correlation (p<0.001, r=0.27) was found between plasma SSAO and serum ACE activity in patients untreated with ACE inhibitors or angiotensin II receptor antagonists (n=221), but plasma SSAO did not differ by ACE I/D genotype. Plasma SSAO correlated positively with duration of diabetes, HbA(1)c and plasma renin, and negatively with plasma angiotensinogen and body mass index. A multiple regression analysis including these variables resulted in serum ACE activity (p<0.001), ACE genotype (negatively, p<0.001) and HbA(1)c (p=0.023) as explaining variables., Conclusions/interpretation: Results suggest that a common factor is involved in the regulation of both plasma SSAO and serum ACE, which is different from the genetic determination of ACE activity.
- Published
- 2005
- Full Text
- View/download PDF
8. Prediction of severe hypoglycaemia by angiotensin-converting enzyme activity and genotype in type 1 diabetes.
- Author
-
Pedersen-Bjergaard U, Agerholm-Larsen B, Pramming S, Hougaard P, and Thorsteinsson B
- Subjects
- Adult, Alleles, Awareness, C-Peptide deficiency, Female, Genotype, Humans, Hypoglycemia psychology, Male, Middle Aged, Multivariate Analysis, Peptidyl-Dipeptidase A genetics, Prognosis, Retrospective Studies, Risk Factors, Severity of Illness Index, Diabetes Mellitus, Type 1 genetics, Diabetes Mellitus, Type 1 metabolism, Hypoglycemia blood, Peptidyl-Dipeptidase A metabolism
- Abstract
Aims/hypothesis: We have previously shown a strong relationship between high angiotensin-converting enzyme (ACE) activity, presence of the deletion (D) allele of the ACEgene and recall of severe hypoglycaemic events in patients with Type 1 diabetes. This study was carried out to assess this relationship prospectively., Methods: We followed 171 adult outpatients with Type 1 diabetes in a one-year observational study with the recording of severe hypoglycaemia. Participants were characterised by serum ACE activity and ACE genotype and not treated with ACE inhibitors or angiotensin II receptor antagonists., Results: There was a positive relationship between serum ACE activity and rate of severe hypoglycaemia with a 2.7 times higher rate in the fourth quartile of ACE activity compared to the first quartile (p=0.0007). A similar relationship was observed for the subset of episodes with coma (2.9 times higher rate in fourth quartile compared to first quartile; p=0.048). The impact of serum ACE activity was most pronounced in C-peptide negative subjects (4.2 times higher rate in fourth quartile compared to first quartile; p=0.003), and in this subgroup carriers of the D allele of the ACEgene had higher rates of severe hypoglycaemia compared to the group homozygous for the insertion (I) allele. In a multiple regression analysis high serum ACE activity and impaired awareness of hypoglycaemia were identified as the only significant predictors of severe hypoglycemia., Conclusion: High ACE activity and the presence of the D allele of the ACE gene predict a high rate of severe hypoglycaemia in Type 1 diabetes.
- Published
- 2003
- Full Text
- View/download PDF
9. Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis.
- Author
-
Lanng S, Thorsteinsson B, Nerup J, and Koch C
- Subjects
- Adolescent, Adult, Body Height, Body Mass Index, Body Weight, Child, Child, Preschool, Cystic Fibrosis complications, Diabetes Complications, Female, Humans, Male, Matched-Pair Analysis, Pancreas physiopathology, Prediabetic State complications, Respiratory Function Tests, Retrospective Studies, Cystic Fibrosis physiopathology, Diabetes Mellitus physiopathology, Prediabetic State physiopathology
- Abstract
The impact of pre-diabetes on clinical status was retrospectively studied in 38 cystic fibrosis (CF) patients with diabetes mellitus (DM) and 38 non-diabetic CF patients (control patients), matched in pairs for age, sex, and chronic Pseudomonas aeruginosa lung infection. Quarterly parameters of CF clinical status were collected for 6 years prior to the diagnosis of DM in the index case. Compared to the control patients, decreases in body weight, body mass index (BMI), forced expiratory volume in 1s (FEV1), and forced vital capacity (FVC) and an increase in the daily intake of pancreatic enzyme capsules were found in the pre-diabetic patients. Statistically significant differences in body weight, BMI, FEV1, FVC, and intake of pancreatic enzyme capsules between pre-diabetic and control patients emerged 4, 4, 1.25, 3 and 4.5 years prior to the diagnosis of DM, respectively. The number of lung infections did not differ between the two groups of patients. Thus, when DM develops in CF patients, an insidious decline in overall clinical status is observed for years prior to its diagnosis. Whether clinical deterioration in CF leads to DM, or pre-diabetes results in declining CF clinical status is presently unknown. Accumulating evidence suggests that the latter may be the case since insulin therapy seems to improve lung function in CF.
- Published
- 1992
- Full Text
- View/download PDF
10. Non-linearity of insulin kinetics.
- Author
-
Thorsteinsson B, Fugleberg S, and Binder C
- Subjects
- Diabetes Mellitus, Type 1 metabolism, Humans, Insulin metabolism, Kinetics, Diabetes Mellitus, Type 1 blood, Insulin blood
- Published
- 1986
- Full Text
- View/download PDF
11. The relationship between plasma concentration and plasma disappearance rate of immunoreactive insulin in normal subjects.
- Author
-
Fugleberg S, Kølendorf K, Thorsteinsson B, Bliddal H, Lund B, and Bojsen F
- Subjects
- Antigens, Humans, Insulin immunology, Kinetics, Models, Biological, Insulin blood
- Abstract
To investigate the mechanism of insulin degradation in normal subjects, a kinetic model of insulin disappearance was constructed: insulin was assumed to be extracted from plasma by two independent processes, one saturable and one non-saturable. On the basis of these assumptions, a linear (non-proportional) relationship between steady-state plasma insulin concentration and steady-state plasma disappearance rate was predicted over the concentration range studied. Constant infusion experiments were performed on eight healthy normal subjects, normoglycaemia and fasting plasma C-peptide concentrations being maintained during the experiments. Agreement was found between the predictions of the model and the experimental results, and it is concluded that insulin degradation in normal subjects may be described in terms of two processes: one that is saturated at physiological plasma insulin concentrations and one that is apparently non-saturable over a wide concentration range.
- Published
- 1982
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.